A new proposed bill in Congress will seek to offer insurance to players in the marijuana industry.

The bill, called the Clarifying Law Around Insurance Marijuana (CLAIM) Act, was introduced on Monday (July 29) and sponsored by representatives Nydia M. Velázquez (D-NY) and Steve Stivers (R-OH).

The bipartisan CLAIM Act would create a federal safe pass so insurers can engage the marijuana industry, despite the federal illegality of operations related to the plant.

“Without this legislation, insurers will understandably be reticent to insure businesses operating in the cannabis sector,” Velázquez said in an announcement. “This means a legal cannabis distributor whose product is ruined from a flood or fire could lose all their capital and their livelihood.

Due to the federal rules surrounding the marijuana industry, operators must carry on business operations without any insurance for their crops and land.

Despite the rush in legal cannabis programs at the state level, marijuana businesses face a slew of challenges from the lack of federal clarity.

A variety of proposed bills have appeared that would offer relief to the marijuana industry either via banking or insurance options, since the drug remains illegal in the eyes of the federal government.

In March, the House Financial Services Committee voted in favor of the Secure and Fair Enforcement Banking Act of 2019, otherwise known as the SAFE Banking Act. After being introduced and recommended by the Congressional committee, the bill awaits activity from the Senate.

On July 23, the Senate Banking Committee held a hearing, “Challenges for Cannabis and Banking: Outside Perspectives,” and listened to testimony on the needs of the cannabis industry.

According to a report from Marijuana Moment, the CLAIM Act resembles a recently announced Senate bill from Senator Bob Menendez (D-NJ).

The bill from Velázquez would also look to create a brand new study from the Government Accountability Office about the challenges women and minority entrepreneurs face when trying to enter the industry.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.

Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/

Keep reading... Show less